位置:首页 > 蛋白库 > BLT1_ECOLX
BLT1_ECOLX
ID   BLT1_ECOLX              Reviewed;         291 AA.
AC   Q47066;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 107.
DE   RecName: Full=Beta-lactamase Toho-1;
DE            EC=3.5.2.6;
DE   Flags: Precursor;
GN   Name=bla;
OS   Escherichia coli.
OG   Plasmid pMTY001.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=562;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=TUH12191; PLASMID=pMTY001;
RX   PubMed=8619581; DOI=10.1128/aac.39.10.2269;
RA   Ishii Y., Ohno A., Taguchi H., Imajo S., Ishiguro M., Matsuzawa H.;
RT   "Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A
RT   beta-lactamase isolated from Escherichia coli.";
RL   Antimicrob. Agents Chemother. 39:2269-2275(1995).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF MUTANT ALA-169.
RC   STRAIN=TUH12191; PLASMID=pMTY001;
RX   PubMed=9925786; DOI=10.1006/jmbi.1998.2432;
RA   Ibuka A., Taguchi A., Ishiguro M., Fushinobu S., Ishii Y., Kamitori S.,
RA   Okuyama K., Yamaguchi K., Konno M., Matsuzawa H.;
RT   "Crystal structure of the E166A mutant of extended-spectrum beta-lactamase
RT   Toho-1 at 1.8 A resolution.";
RL   J. Mol. Biol. 285:2079-2087(1999).
CC   -!- FUNCTION: Has strong cefotaxime-hydrolyzing activity.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-lactam + H2O = a substituted beta-amino acid;
CC         Xref=Rhea:RHEA:20401, ChEBI:CHEBI:15377, ChEBI:CHEBI:35627,
CC         ChEBI:CHEBI:140347; EC=3.5.2.6; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10101};
CC   -!- SUBUNIT: Monomer.
CC   -!- SIMILARITY: Belongs to the class-A beta-lactamase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D37830; BAA07082.1; -; Genomic_DNA.
DR   PIR; JP0074; JP0074.
DR   RefSeq; WP_063860054.1; NG_048995.1.
DR   PDB; 1BZA; X-ray; 1.80 A; A=30-290.
DR   PDB; 1IYO; X-ray; 1.80 A; A=30-291.
DR   PDB; 1IYP; X-ray; 2.00 A; A=30-291.
DR   PDB; 1IYQ; X-ray; 2.10 A; A=30-291.
DR   PDB; 1IYS; X-ray; 1.65 A; A=31-291.
DR   PDB; 1WE4; X-ray; 1.70 A; A=30-291.
DR   PDB; 2WYX; Neutron; 2.10 A; A=33-288.
DR   PDB; 2XQZ; Neutron; 2.10 A; A=32-291.
DR   PDB; 2XR0; X-ray; 2.20 A; A=32-291.
DR   PDB; 2ZQ7; X-ray; 0.94 A; A=30-291.
DR   PDB; 2ZQ8; X-ray; 1.03 A; A=30-291.
DR   PDB; 2ZQ9; X-ray; 1.07 A; A=30-291.
DR   PDB; 2ZQA; X-ray; 0.95 A; A=30-291.
DR   PDB; 2ZQC; X-ray; 1.07 A; A=30-291.
DR   PDB; 2ZQD; X-ray; 1.19 A; A=30-291.
DR   PDB; 4BD0; X-ray; 1.21 A; A=31-291.
DR   PDB; 4BD1; Neutron; 2.00 A; A=31-291.
DR   PDB; 4C3Q; Neutron; 2.20 A; A=31-291.
DR   PDB; 4X69; X-ray; 1.42 A; A/B=30-291.
DR   PDB; 5KMW; X-ray; 1.10 A; A=33-288.
DR   PDB; 5KSC; Neutron; 2.10 A; A=31-291.
DR   PDB; 6C78; Neutron; 1.75 A; A=32-291.
DR   PDB; 6C79; X-ray; 1.10 A; A=32-291.
DR   PDB; 6C7A; X-ray; 1.05 A; A=32-291.
DR   PDB; 6U58; Other; 1.90 A; A=31-291.
DR   PDBsum; 1BZA; -.
DR   PDBsum; 1IYO; -.
DR   PDBsum; 1IYP; -.
DR   PDBsum; 1IYQ; -.
DR   PDBsum; 1IYS; -.
DR   PDBsum; 1WE4; -.
DR   PDBsum; 2WYX; -.
DR   PDBsum; 2XQZ; -.
DR   PDBsum; 2XR0; -.
DR   PDBsum; 2ZQ7; -.
DR   PDBsum; 2ZQ8; -.
DR   PDBsum; 2ZQ9; -.
DR   PDBsum; 2ZQA; -.
DR   PDBsum; 2ZQC; -.
DR   PDBsum; 2ZQD; -.
DR   PDBsum; 4BD0; -.
DR   PDBsum; 4BD1; -.
DR   PDBsum; 4C3Q; -.
DR   PDBsum; 4X69; -.
DR   PDBsum; 5KMW; -.
DR   PDBsum; 5KSC; -.
DR   PDBsum; 6C78; -.
DR   PDBsum; 6C79; -.
DR   PDBsum; 6C7A; -.
DR   PDBsum; 6U58; -.
DR   AlphaFoldDB; Q47066; -.
DR   SMR; Q47066; -.
DR   ChEMBL; CHEMBL1697675; -.
DR   DrugBank; DB08375; (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid.
DR   DrugBank; DB03450; Cephalothin Group.
DR   KEGG; ag:BAA07082; -.
DR   BRENDA; 3.5.2.6; 2026.
DR   SABIO-RK; Q47066; -.
DR   EvolutionaryTrace; Q47066; -.
DR   GO; GO:0008800; F:beta-lactamase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030655; P:beta-lactam antibiotic catabolic process; IEA:InterPro.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.710.10; -; 1.
DR   InterPro; IPR012338; Beta-lactam/transpept-like.
DR   InterPro; IPR045155; Beta-lactam_cat.
DR   InterPro; IPR000871; Beta-lactam_class-A.
DR   InterPro; IPR023650; Beta-lactam_class-A_AS.
DR   PANTHER; PTHR35333; PTHR35333; 1.
DR   Pfam; PF13354; Beta-lactamase2; 1.
DR   PRINTS; PR00118; BLACTAMASEA.
DR   SUPFAM; SSF56601; SSF56601; 1.
DR   PROSITE; PS00146; BETA_LACTAMASE_A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; Hydrolase; Plasmid; Signal.
FT   SIGNAL          1..29
FT   CHAIN           30..291
FT                   /note="Beta-lactamase Toho-1"
FT                   /id="PRO_0000016994"
FT   ACT_SITE        73
FT                   /note="Acyl-ester intermediate"
FT   BINDING         237..239
FT                   /ligand="substrate"
FT   HELIX           33..43
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   STRAND          46..54
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   TURN            55..57
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   STRAND          60..64
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           72..75
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           76..87
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           93..95
FT                   /evidence="ECO:0007829|PDB:5KMW"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           112..115
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   STRAND          118..121
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           122..131
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           135..145
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           148..157
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           186..198
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   STRAND          199..202
FT                   /evidence="ECO:0007829|PDB:2ZQ8"
FT   HELIX           204..215
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   TURN            221..223
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           224..227
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   STRAND          232..241
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   TURN            242..244
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   STRAND          245..253
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   STRAND          255..257
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   STRAND          260..267
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
FT   HELIX           277..288
FT                   /evidence="ECO:0007829|PDB:2ZQ7"
SQ   SEQUENCE   291 AA;  31447 MW;  83FC0CD9CD41E7C0 CRC64;
     MMTQSIRRSM LTVMATLPLL FSSATLHAQA NSVQQQLEAL EKSSGGRLGV ALINTADNSQ
     ILYRADERFA MCSTSKVMAA AAVLKQSESD KHLLNQRVEI KKSDLVNYNP IAEKHVNGTM
     TLAELGAAAL QYSDNTAMNK LIAHLGGPDK VTAFARSLGD ETFRLDRTEP TLNTAIPGDP
     RDTTTPLAMA QTLKNLTLGK ALAETQRAQL VTWLKGNTTG SASIRAGLPK SWVVGDKTGS
     GDYGTTNDIA VIWPENHAPL VLVTYFTQPE QKAERRRDIL AAAAKIVTHG F
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024